The Experts below are selected from a list of 39042 Experts worldwide ranked by ideXlab platform
Ariane Van Der Straten - One of the best experts on this subject based on the ideXlab platform.
-
we are not the same african women s view of multipurpose prevention Products in the trio clinical study
International Journal of Women's Health, 2019Co-Authors: Mary Kate Shapleyquinn, Kgahlisho Manenzhe, Kawango Agot, Alexandra M Minnis, Ariane Van Der StratenAbstract:Purpose Unintended pregnancy and HIV infection present dual risks for young women in sub-Saharan Africa. New multipurpose prevention technologies (MPTs) are in development to simultaneously prevent unintended pregnancy and HIV, but there is a need for end-user research to ensure these Products suit women's needs. The Tablet, Rings and Injectables as Options (TRIO) for women study took place in Kisumu, Kenya, and Soshanguve, South Africa, with the goal of eliciting young women's feedback on three potential MPTs. Methods Women in TRIO used three placebo Products that represented potential MPTs: daily oral tablets, monthly vaginal rings, and monthly dual injections in a randomized crossover design followed by a period in which they chose a Product to use. Eighty-eight TRIO participants completed in-depth interviews and focus group discussions to understand their experiences using each Product. Qualitative analyses were conducted after stratifying by Product Preference at the end of the crossover period. Results The majority (65%) of participants preferred injections, with the remainder evenly split between tablets and rings. Discussions of Preference for one Product were closely linked with expressed dislike of another Product's attributes. Participants recognized heterogeneity in Preferences and choices across users and stressed the need for multiple MPT options that confer a low burden on women's daily lives. Conclusion Rather than choosing a Product to use based on the Product's perceived advantages, women's choices were based on the unfavorable attributes of other TRIO Products. Moreover, the importance that women placed on a given disadvantage varied. Disadvantages that women deemed as most important emerged as a greater driver of Product Preference than selecting Products based on their advantages and favorable characteristics.
-
end users Product Preference across three multipurpose prevention technology delivery forms baseline results from young women in kenya and south africa
Aids and Behavior, 2018Co-Authors: Rachel Weinrib, Kgahlisho Manenzhe, Kawango Agot, Alexandra M Minnis, Ariane Van Der Straten, Khatija Ahmed, Fred Owino, Helen ChengAbstract:A multipurpose prevention technology (MPT) that combines HIV and pregnancy prevention is a promising women’s health intervention, particularly for young women. However, little is known about the drivers of acceptability and Product choice for MPTs in this population. This paper explores approval ratings and stated choice across three different MPT delivery forms among potential end-users. The Trio Study was a mixed-methods study in women ages 18–30 that examined acceptability of three MPT delivery forms: oral tablets, injections, and vaginal ring. Approval ratings and stated choice among the Products was collected at baseline. Factors influencing stated Product choice were explored using multivariable multinomial logistic regression. The majority (62%) of women in Trio stated they would choose injections, 27% would choose tablets and 11% would choose the ring. Significant predictors of choice included past experience with similar contraceptive delivery forms, age, and citing frequency of use as important. Ring choice was higher for older (25–30) women than for younger (18–24) women (aRR = 3.1; p < 0.05). These results highlight the importance of familiarity in MPT Product choice of potential for variations in MPT Preference by age.
Alexandra M Minnis - One of the best experts on this subject based on the ideXlab platform.
-
we are not the same african women s view of multipurpose prevention Products in the trio clinical study
International Journal of Women's Health, 2019Co-Authors: Mary Kate Shapleyquinn, Kgahlisho Manenzhe, Kawango Agot, Alexandra M Minnis, Ariane Van Der StratenAbstract:Purpose Unintended pregnancy and HIV infection present dual risks for young women in sub-Saharan Africa. New multipurpose prevention technologies (MPTs) are in development to simultaneously prevent unintended pregnancy and HIV, but there is a need for end-user research to ensure these Products suit women's needs. The Tablet, Rings and Injectables as Options (TRIO) for women study took place in Kisumu, Kenya, and Soshanguve, South Africa, with the goal of eliciting young women's feedback on three potential MPTs. Methods Women in TRIO used three placebo Products that represented potential MPTs: daily oral tablets, monthly vaginal rings, and monthly dual injections in a randomized crossover design followed by a period in which they chose a Product to use. Eighty-eight TRIO participants completed in-depth interviews and focus group discussions to understand their experiences using each Product. Qualitative analyses were conducted after stratifying by Product Preference at the end of the crossover period. Results The majority (65%) of participants preferred injections, with the remainder evenly split between tablets and rings. Discussions of Preference for one Product were closely linked with expressed dislike of another Product's attributes. Participants recognized heterogeneity in Preferences and choices across users and stressed the need for multiple MPT options that confer a low burden on women's daily lives. Conclusion Rather than choosing a Product to use based on the Product's perceived advantages, women's choices were based on the unfavorable attributes of other TRIO Products. Moreover, the importance that women placed on a given disadvantage varied. Disadvantages that women deemed as most important emerged as a greater driver of Product Preference than selecting Products based on their advantages and favorable characteristics.
-
end users Product Preference across three multipurpose prevention technology delivery forms baseline results from young women in kenya and south africa
Aids and Behavior, 2018Co-Authors: Rachel Weinrib, Kgahlisho Manenzhe, Kawango Agot, Alexandra M Minnis, Ariane Van Der Straten, Khatija Ahmed, Fred Owino, Helen ChengAbstract:A multipurpose prevention technology (MPT) that combines HIV and pregnancy prevention is a promising women’s health intervention, particularly for young women. However, little is known about the drivers of acceptability and Product choice for MPTs in this population. This paper explores approval ratings and stated choice across three different MPT delivery forms among potential end-users. The Trio Study was a mixed-methods study in women ages 18–30 that examined acceptability of three MPT delivery forms: oral tablets, injections, and vaginal ring. Approval ratings and stated choice among the Products was collected at baseline. Factors influencing stated Product choice were explored using multivariable multinomial logistic regression. The majority (62%) of women in Trio stated they would choose injections, 27% would choose tablets and 11% would choose the ring. Significant predictors of choice included past experience with similar contraceptive delivery forms, age, and citing frequency of use as important. Ring choice was higher for older (25–30) women than for younger (18–24) women (aRR = 3.1; p < 0.05). These results highlight the importance of familiarity in MPT Product choice of potential for variations in MPT Preference by age.
Kgahlisho Manenzhe - One of the best experts on this subject based on the ideXlab platform.
-
we are not the same african women s view of multipurpose prevention Products in the trio clinical study
International Journal of Women's Health, 2019Co-Authors: Mary Kate Shapleyquinn, Kgahlisho Manenzhe, Kawango Agot, Alexandra M Minnis, Ariane Van Der StratenAbstract:Purpose Unintended pregnancy and HIV infection present dual risks for young women in sub-Saharan Africa. New multipurpose prevention technologies (MPTs) are in development to simultaneously prevent unintended pregnancy and HIV, but there is a need for end-user research to ensure these Products suit women's needs. The Tablet, Rings and Injectables as Options (TRIO) for women study took place in Kisumu, Kenya, and Soshanguve, South Africa, with the goal of eliciting young women's feedback on three potential MPTs. Methods Women in TRIO used three placebo Products that represented potential MPTs: daily oral tablets, monthly vaginal rings, and monthly dual injections in a randomized crossover design followed by a period in which they chose a Product to use. Eighty-eight TRIO participants completed in-depth interviews and focus group discussions to understand their experiences using each Product. Qualitative analyses were conducted after stratifying by Product Preference at the end of the crossover period. Results The majority (65%) of participants preferred injections, with the remainder evenly split between tablets and rings. Discussions of Preference for one Product were closely linked with expressed dislike of another Product's attributes. Participants recognized heterogeneity in Preferences and choices across users and stressed the need for multiple MPT options that confer a low burden on women's daily lives. Conclusion Rather than choosing a Product to use based on the Product's perceived advantages, women's choices were based on the unfavorable attributes of other TRIO Products. Moreover, the importance that women placed on a given disadvantage varied. Disadvantages that women deemed as most important emerged as a greater driver of Product Preference than selecting Products based on their advantages and favorable characteristics.
-
end users Product Preference across three multipurpose prevention technology delivery forms baseline results from young women in kenya and south africa
Aids and Behavior, 2018Co-Authors: Rachel Weinrib, Kgahlisho Manenzhe, Kawango Agot, Alexandra M Minnis, Ariane Van Der Straten, Khatija Ahmed, Fred Owino, Helen ChengAbstract:A multipurpose prevention technology (MPT) that combines HIV and pregnancy prevention is a promising women’s health intervention, particularly for young women. However, little is known about the drivers of acceptability and Product choice for MPTs in this population. This paper explores approval ratings and stated choice across three different MPT delivery forms among potential end-users. The Trio Study was a mixed-methods study in women ages 18–30 that examined acceptability of three MPT delivery forms: oral tablets, injections, and vaginal ring. Approval ratings and stated choice among the Products was collected at baseline. Factors influencing stated Product choice were explored using multivariable multinomial logistic regression. The majority (62%) of women in Trio stated they would choose injections, 27% would choose tablets and 11% would choose the ring. Significant predictors of choice included past experience with similar contraceptive delivery forms, age, and citing frequency of use as important. Ring choice was higher for older (25–30) women than for younger (18–24) women (aRR = 3.1; p < 0.05). These results highlight the importance of familiarity in MPT Product choice of potential for variations in MPT Preference by age.
Kawango Agot - One of the best experts on this subject based on the ideXlab platform.
-
we are not the same african women s view of multipurpose prevention Products in the trio clinical study
International Journal of Women's Health, 2019Co-Authors: Mary Kate Shapleyquinn, Kgahlisho Manenzhe, Kawango Agot, Alexandra M Minnis, Ariane Van Der StratenAbstract:Purpose Unintended pregnancy and HIV infection present dual risks for young women in sub-Saharan Africa. New multipurpose prevention technologies (MPTs) are in development to simultaneously prevent unintended pregnancy and HIV, but there is a need for end-user research to ensure these Products suit women's needs. The Tablet, Rings and Injectables as Options (TRIO) for women study took place in Kisumu, Kenya, and Soshanguve, South Africa, with the goal of eliciting young women's feedback on three potential MPTs. Methods Women in TRIO used three placebo Products that represented potential MPTs: daily oral tablets, monthly vaginal rings, and monthly dual injections in a randomized crossover design followed by a period in which they chose a Product to use. Eighty-eight TRIO participants completed in-depth interviews and focus group discussions to understand their experiences using each Product. Qualitative analyses were conducted after stratifying by Product Preference at the end of the crossover period. Results The majority (65%) of participants preferred injections, with the remainder evenly split between tablets and rings. Discussions of Preference for one Product were closely linked with expressed dislike of another Product's attributes. Participants recognized heterogeneity in Preferences and choices across users and stressed the need for multiple MPT options that confer a low burden on women's daily lives. Conclusion Rather than choosing a Product to use based on the Product's perceived advantages, women's choices were based on the unfavorable attributes of other TRIO Products. Moreover, the importance that women placed on a given disadvantage varied. Disadvantages that women deemed as most important emerged as a greater driver of Product Preference than selecting Products based on their advantages and favorable characteristics.
-
end users Product Preference across three multipurpose prevention technology delivery forms baseline results from young women in kenya and south africa
Aids and Behavior, 2018Co-Authors: Rachel Weinrib, Kgahlisho Manenzhe, Kawango Agot, Alexandra M Minnis, Ariane Van Der Straten, Khatija Ahmed, Fred Owino, Helen ChengAbstract:A multipurpose prevention technology (MPT) that combines HIV and pregnancy prevention is a promising women’s health intervention, particularly for young women. However, little is known about the drivers of acceptability and Product choice for MPTs in this population. This paper explores approval ratings and stated choice across three different MPT delivery forms among potential end-users. The Trio Study was a mixed-methods study in women ages 18–30 that examined acceptability of three MPT delivery forms: oral tablets, injections, and vaginal ring. Approval ratings and stated choice among the Products was collected at baseline. Factors influencing stated Product choice were explored using multivariable multinomial logistic regression. The majority (62%) of women in Trio stated they would choose injections, 27% would choose tablets and 11% would choose the ring. Significant predictors of choice included past experience with similar contraceptive delivery forms, age, and citing frequency of use as important. Ring choice was higher for older (25–30) women than for younger (18–24) women (aRR = 3.1; p < 0.05). These results highlight the importance of familiarity in MPT Product choice of potential for variations in MPT Preference by age.
Adamantios Diamantopoulos - One of the best experts on this subject based on the ideXlab platform.
-
consumer xenocentrism as determinant of foreign Product Preference a system justification perspective
Journal of International Marketing, 2016Co-Authors: George Balabanis, Adamantios DiamantopoulosAbstract:AbstractForeign and domestic Product purchase behavior largely depends on consumer predispositions. The dominant construct in international marketing literature explaining such behavior has been consumer ethnocentrism, which is conceptually anchored in social identity theory. However, such a perspective overlooks evidence that certain consumers are consistently attracted by the “foreignness” of a Product. Drawing from system justification theory, the present investigation conceptualizes and provides an empirical test of the consumer xenocentrism construct that is intended to explain consumer attraction toward foreign Products. Using survey data from five complementary studies, the authors develop and validate a new scale (the C-XENSCALE) to measure consumers’ xenocentric tendencies and offer extensive evidence on its ability to explain consumer Preferences for foreign Products. The authors discuss implications of the findings for theory and managerial practice and identify future research directions.
-
consumer cosmopolitanism review and replication of the cymyc scale
Journal of Business Research, 2009Co-Authors: Petra Riefler, Adamantios DiamantopoulosAbstract:Abstract Extant marketing literature mainly focuses on explaining why consumers might prefer domestic Products and refrain from buying foreign Products but, however, is weak in explaining why consumers might intentionally opt for foreign Products. Against this background, consumer cosmopolitanism has gained increasing attention as a potentially relevant consumer characteristic for explaining foreign Product Preference and choice. However, empirical evidence on the impact of consumer cosmopolitanism on consumption behavior remains scarce. This paper identifies the absence of an appropriate measurement instrument as a main reason for this lack of empirical studies by providing (a) a review of cosmopolitanism scales used in other research fields, and (b) a replication with extensions study of the CYMYC scale, the only consumer cosmopolitanism scale currently available. The findings highlight a need for a new scale to measure the consumer cosmopolitanism construct. To stimulate further research in this direction, the paper proposes a conceptual definition of consumer cosmopolitanism along with a nomological network to guide the scale development process.